z-logo
Premium
Declining antibody levels after hepatitis B vaccination in Down syndrome: A need for booster vaccination?
Author(s) -
Eijsvoogel Noortje B.,
Hollegien Mirjam I.,
Bok Vinus L. A.,
Derksen−Lubsen Arda G.,
Dikken Felix P. J.,
Leenders Sander A. C. A. P.,
Pijning Arjan.,
Post Erica,
Wojciechowski Marek,
Hilbink Mirrian,
de Vries Esther
Publication year - 2017
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.24813
Subject(s) - booster (rocketry) , titer , vaccination , medicine , virology , hepatitis b , booster dose , antibody , immunology , hepatitis b virus , pediatrics , virus , physics , astronomy
We determined the anti‐HBs titer in 227 children of all ages with Down syndrome (DS). Only 48.1% (95%CI: 35.1‐61.3) of the DS children aged 7‐10 years and 31.9% (95%CI: 22.1‐43.6) of the DS children aged >10 years had a protective anti‐HBs titer (≥10 IU/L). The geometric mean anti‐HBs titer was significantly lower in the DS children; this suggests booster vaccination for HBV may be needed.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom